CasLoc logo
All Cases PTAB Litigations UPC Oppositions

SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. v. PAR PHARMACEUTICAL, INC.

3:10-cv-04837

Overview

Case Number 3:10-cv-04837
Filing Date 2010-09-20
Status Terminated
Termination Date 2014-04-14
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Plaintiff

PAR PHARMACEUTICAL, INC. Operating Company

Represented By

2 Attorneys Listed

Counter Defendant

MSD CONSUMER PRODUCTS, INC. Operating Company

Represented By

1 Attorneys Listed

SANTARUS, INC. Operating Company

Represented By

2 Attorneys Listed

THE CURATORS OF THE UNIVERSITY OF MISSOURI NPE (University / Research)

Represented By

2 Attorneys Listed

SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. Operating Company

Represented By

2 Attorneys Listed

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2007-12-20
1:07-cv-00827

Santarus Inc. v. Par Pharmaceutical Inc.

U.S. Family Sibling (["US6699885", "US6489346", "US6645988", "US6780882"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7399772
Substituted benzimidazole dosage forms and method of using same
Filed: 2003-08-15
Issued: 2008-07-15
Expired (Term Ended)
Expires: 2023-08-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

10

Dispositive

0

Granted

0

Denied

0

Pending / Review

10

Motions by Category

Motion to Strike / Sanctions 2 Procedural / Extension Motion 1 Claim Construction / Markman Filing 7

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
Transcript of MARKMAN HEARING held on 7/15/2013, before Judge PETER G. SHERIDAN. Court Reporter/Transcriber Frank Gable (856-889-4761). NOTICE REGARDING REDACTI...
Entry #122 • 2014-01-07 Document →
Claim Construction / Markman Filing Pending / Under Review
Minute Entry for proceedings held before Judge Peter G. Sheridan: Markman Hearing held on 7/15/2013. (Decision Reserved) (Court Reporter/Recorder Frank Gable.) ...
Entry #94 • 2013-07-15 Document →
Claim Construction / Markman Filing Pending / Under Review
MARKMAN RESPONSE BRIEF re 59 Markman Opening Brief,, (Attachments: # 1 Declaration of Stephen Yang in Support of Par's Responsive Claim Construction Brief, # 2 ...
Entry #74 • 2013-06-21 Document →
Claim Construction / Markman Filing Pending / Under Review
BRIEF in Support filed by PAR PHARMACEUTICAL, INC. re 60 MOTION to Seal (Attachments: # 1 Declaration of Stephen Yang, # 2 Proposed Findings of Fact and Conclus...
Entry #67 • 2013-05-31 Document →
Claim Construction / Markman Filing Pending / Under Review
MARKMAN OPENING BRIEF (Attachments: # 1 Declaration of Stephen Yang in Support of Par's Opening Claim Construction Brief, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhi...
Entry #61 • 2013-05-17 Document →
Claim Construction / Markman Filing Pending / Under Review
STATEMENT (Joint Claim Construction and Prehearing) by MSD CONSUMER PRODUCTS, INC., SANTARUS, INC., THE CURATORS OF THE UNIVERSITY OF MISSOURI. (Attachments: # ...
Entry #54 • 2013-03-29 Document →

Docket Entries

(131 total)
Motion to Strike / Sanctions Pending / Under Review

COMPLAINT against PAR PHARMACEUTICAL, INC. (Filing fee $350 receipt number 0312-3328763), filed by SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC., THE CURATORS OF THE UNIVERSITY OF MISSOURI. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Certification Pursuant to Local Civil Rule 11.2, # 7 Civil Cover Sheet)(mmh) (Entered: 09/22/2010)

Entry #1 • 2010-09-20
1

Corporate Disclosure Statement by SANTARUS, INC., SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC., THE CURATORS OF THE UNIVERSITY OF MISSOURI. (mmh) (Entered: 09/22/2010)

Entry #2 • 2010-09-20
1

SUMMONS ISSUED as to PAR PHARMACEUTICAL, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *Melissa M. Haneke* (mmh) (Entered: 09/22/2010)

Entry #3 • 2010-09-22
1

AO120 Patent/Trademark Form filed. (mmh) (Entered: 09/22/2010)

Entry #4 • 2010-09-22
1

NOTICE of Appearance by CARRIE ANN LONGSTAFF on behalf of SANTARUS, INC., SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC., THE CURATORS OF THE UNIVERSITY OF MISSOURI (LONGSTAFF, CARRIE) (Entered: 09/23/2010)

Entry #5 • 2010-09-23
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc